StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30524% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Eton Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was $15.14M, up 23.7% year over year. For fiscal 2025 it was $10.52M, up 986.1% from the year before. The highest annual figure on record is $10.52M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$10.52M+986.1%
FY2024Dec 31, 2024$969.00K-85.8%
FY2023Dec 31, 2023$6.82M+41.4%
FY2022Dec 31, 2022$4.82M–
FY2021Dec 31, 2021-$4.72M–
FY2020Dec 31, 2020-$22.35M–
FY2019Dec 31, 2019-$18.03M–
FY2018Dec 31, 2018-$8.15M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$7.26M-8.8%
Q1 FY2026Mar 31, 2026$7.41M+254.3%
Q4 FY2025Dec 31, 2025-$11.55M–
Q3 FY2025Sep 30, 2025$12.03M+307.4%
Q2 FY2025Jun 30, 2025$7.96M+534.2%
Q1 FY2025Mar 31, 2025$2.09M–
Q4 FY2024Dec 31, 2024-$765.00K-297.7%
Q3 FY2024Sep 30, 2024$2.95M+238.1%
Q2 FY2024Jun 30, 2024$1.26M-82.3%
Q1 FY2024Mar 31, 2024-$2.47M–
Q4 FY2023Dec 31, 2023$387.00K-86.4%
Q3 FY2023Sep 30, 2023$873.00K–
Q2 FY2023Jun 30, 2023$7.10M+188.6%
Q1 FY2023Mar 31, 2023-$1.55M-226.6%
Q4 FY2022Dec 31, 2022$2.84M–
Q3 FY2022Sep 30, 2022-$1.70M–
Q2 FY2022Jun 30, 2022$2.46M–
Q1 FY2022Mar 31, 2022$1.22M-67.1%
Q4 FY2021Dec 31, 2021-$5.12M–
Q3 FY2021Sep 30, 2021-$2.95M–
Q2 FY2021Jun 30, 2021-$369.00K–
Q1 FY2021Mar 31, 2021$3.72M–
Q4 FY2020Dec 31, 2020-$7.18M–
Q3 FY2020Sep 30, 2020-$5.09M–
Q2 FY2020Jun 30, 2020-$2.85M–
Q1 FY2020Mar 31, 2020-$7.22M–
Q4 FY2019Dec 31, 2019-$3.85M–
Q3 FY2019Sep 30, 2019-$3.22M–
Q2 FY2019Jun 30, 2019-$4.20M–
Q1 FY2019Mar 31, 2019-$6.77M–
Q4 FY2018Dec 31, 2018-$1.77M–
Q3 FY2018Sep 30, 2018-$2.29M–
Q2 FY2018Jun 30, 2018-$2.23M–
Q1 FY2018Mar 31, 2018-$1.85M–

More Eton Pharmaceuticals figures

See a number that looks wrong?